5 Stocks Dominating Today’s Market Action

4. Erasca Inc. (NASDAQ:ERAS)

Erasca rallied for a second day on Thursday, jumping 13.04 percent to close at $15.26 apiece on strong investor optimism, backed by earlier optimistic coverage from several analysts.

Year-to-date, the company has already seen its stock price soar by 310 percent, making it one of the top-performing stocks this year.

Investors are also positioning portfolios ahead of initial data from clinical trials to test the efficacy of its treatment candidate, ERAS-0015, in patients with RAS-mutant solid tumors in the US and China.

In January this year, ERAS-0015 showed early promising results in one of Erasca Inc.’s (NASDAQ:ERAS) clinical studies, particularly during dose escalations.

According to the company, it saw two confirmed partial responses and one unconfirmed partial response during the clinical study of its pan-RAS molecular glue degrader ERAS-0015.

In addition, more unconfirmed responses were observed in patients taking 8 mg doses, with consistent, linear pharmacokinetics across all dose levels evaluated and no evidence of exposure plateau so far.